Avanti Biosciences

Avanti Biosciences is a biotechnology company focused on the discovery and development of next-generation small molecule therapeutics that modulate protein homeostasis. The company specializes in the identification of molecular glues and targeted protein degraders designed to address previously undruggable targets in neurodegeneration and oncology. By leveraging its proprietary discovery platform, Avanti aims to develop disease-modifying treatments for conditions such as Parkinson's disease and various cancers. The company is led by a team of experienced drug hunters and is headquartered in the San Francisco Bay Area. Avanti's approach focuses on restoring cellular health by selectively removing toxic or disease-causing proteins.